HIT Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

Full Year 2025 Revenue: Increased by 71% to $333.3 million.
Q4 Revenue: Rose by 53% to $7.5 million.
Adjusted EBITDA: For the full year, it was $4.1 million (12.3% of revenue), up 81% year-over-year. Q4 adjusted EBITDA was $300,000, down from $500,000 in Q4 2024.
Net Income: Full year net income was $1.2 million (4% of revenue), up 91% year-over-year. Q4 net income was a loss of $300,000, compared to a loss of $100,000 in Q4 2024.
Operating Cash Flow: Generated $3.1 million in positive operating cash flow for the year.
Distribution Network: Expanded to 858 brokers, TPAs, and agencies, a 34% increase year-over-year. Enrolled employees grew to 22,515, a 23% increase.

2. Strategic Updates and Business Highlights

Market Penetration: HIT is still in the early stages of market penetration within the self-funded health insurance market, with significant growth potential.
Platform Development: Launched the Enhanced Do-It-Yourself Benefit Systems (EDIBS) to improve underwriting efficiency for larger employers.
Three-Year Rate Stabilization Program: Designed to provide pricing stability for employers, particularly appealing to government entities.
AI Integration: Continues to leverage proprietary data and AI to enhance underwriting processes and improve operational efficiency.
Partnerships: Strengthened technology foundation through partnerships, including with Siclim and AWS, to enhance AI-driven capabilities.

3. Forward Guidance and Outlook

2026 Revenue Guidance: Projected revenue between $45 million and $50 million, representing a growth rate of approximately 35% to 50% year-over-year.
Strategic Priorities for 2026: Focus on scaling distribution, enhancing platform capabilities, and expanding into claims administration and cost-containment solutions.

4. Bad News, Challenges, or Points of Concern

Q4 Losses: The company reported a net loss in Q4, attributed to planned reinvestments in growth initiatives and peak enrollment activities.
Long Sales Cycles: The transition into the large employer segment is characterized by long sales cycles, which may delay revenue recognition.
Market Volatility: Potential headwinds from regulatory changes in the healthcare sector, particularly concerning drug pricing and claims management.

5. Notable Q&A Insights

Large Employer Offering: Initial feedback is positive, but sales cycles are lengthy. The company anticipates more significant contributions in 2026.
Three-Year Rate Stabilization: There is considerable interest from municipalities and government entities, with expectations for a formal launch in mid-2026.
AI Applications: HIT is focused on applying AI to improve claims processing and underwriting efficiency, which is seen as a critical area for operational enhancement.
Partnerships and Market Expansion: HIT is exploring additional partnerships to broaden its service offerings and enhance distribution capabilities, with a significant untapped market of over 1 million insurance brokers in the U.S.

Overall, HIT demonstrated strong growth in 2025, with a focus on expanding its market presence and enhancing its technology platform, despite facing challenges related to long sales cycles and market volatility.

HIT — Health In Tech, Inc.